Maria Helena Hilhorst

Title: Maria Helena Hilhorst: Innovator in Oncology Research

Introduction

Maria Helena Hilhorst is a distinguished inventor located in Wageningen, NL, known for her significant contributions to cancer research. She holds four patents that underscore her commitment to developing innovative methods for diagnosing and treating cancer. With a focus on personalized medicine, her inventions have the potential to improve patient outcomes in critical health scenarios.

Latest Patents

Two of Maria’s latest patents exemplify her groundbreaking work in oncology:

1. **Method for determining the estrogen receptor status of breast cancer**: This patent presents a novel approach for determining the estrogen receptor status in patients suffering from breast cancer. The invention aims to provide methods and devices to predict how patients will respond to specific medicaments, focusing on measuring kinase activity through phosphorylation levels in patient samples.

2. **Method for predicting the response of non-small cell lung cancer patients to targeted pharmacotherapy**: In this patent, Maria introduces a method for predicting a patient’s response to targeted pharmacotherapy for non-small cell lung cancer. The invention emphasizes measuring kinase activity and understanding the impact of drug inhibitions by analyzing phosphorylation levels in patient samples.

Career Highlights

Maria has made notable strides in her career, particularly through her work with Pamgene B.V. and its related entity. Her role in these innovative companies has facilitated the practical application of her research, contributing significantly to advancements in oncological treatments and diagnostics.

Collaborations

Maria has collaborated with esteemed colleagues, including Robby Ruijtenbeek and Richard De Wijn. These partnerships have fostered an environment of shared knowledge and innovation, enhancing the development of her patented methods.

Conclusion

Maria Helena Hilhorst stands out as a vital figure in the field of cancer research. Through her inventive patents and collaborations, she continues to push the boundaries of how diseases like breast cancer and non-small cell lung cancer are diagnosed and treated. Her work not only reflects her expertise but also her passion for improving the lives of patients through innovative solutions.